Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
Detection Principle
NucleicAcid-PCR based
Target
Testing Method Category
WHO method(s)
Testing Method
WHO5 (Charité), QIAstat-Dx respiratory panel (QIAGEN), diagnostic algorithm
Testing Method - Additional Info
Method aims to distinguish COVID19 from common infections such as influenza and other respiratory tract diseases
Reported Performance
53.2% patients were covid, others could be excluded
Sample Size
126 patients
Assay Type
Peer-reviewed
yes
Related methods
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements